CSL - Pre Tax Profit


CSL reported $2.61B in Pre-Tax Profit for its fiscal semester ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD -153K 25.59M Mar/2026
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD 19.36M 33.34M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024